The best choice of test at the right cost at the point of decision

Molecular and genetic tests are changing what’s possible in medicine. Diseases may now be diagnosed far earlier. Consumers may understand health risks years before they develop symptoms. And targeted, often expensive, sometimes risky drugs may be prescribed more appropriately. This field is in its infancy, growing fast, and visibility into test selection and effectiveness is frighteningly low.

Advanced Diagnostics Management (ADM) helps plans manage molecular diagnostics (MDx) by giving physicians and clinical labs intelligent, automated decision support tools at the point of decision that enable transparent, immediate access to coverage, network and utilization rules. The result: better control of MDx medical spend

ADM is a comprehensive step-by-step program comprised of tools, content and services, to drive effective use of MDx – and lower medical spend. ADM delivers a very positive return on your investment with these key components:

• Measure volumes and cost through retrospective analysis & benchmarking, with on-going data collection
• Define & codify relevant medical, benefit, network & payment policy
• Manage testing spend by influencing behavior at point-of-care using notification, authorization & orders tools
• Extend program to additional workflows, markets, specialties, etc.